NCT02265510 2020-04-17
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
Incyte Corporation
Phase 1/2 Terminated
Clinical Trials
5 trialsNCT00895687 2015-07-13
Study of Erlotinib in Combination With Bortezomib
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00091117 2013-12-16
Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction
National Cancer Institute (NCI)
Phase 1 Completed
NCT00298779 2008-06-06
Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.
Millennium Pharmaceuticals, Inc.
Phase 1 Completed
NCT00129207 2008-02-11
Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade
Millennium Pharmaceuticals, Inc.
Phase 1 Completed